FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

421949005: Conventional release cutaneous gel (dose form)

Status: current, Defined. Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2614984013 Cutaneous gel (product) en Fully specified name Inactive Initial character case insensitive SNOMED CT core
2617615011 Cutaneous gel en Synonym Active Case insensitive SNOMED CT core
2622860018 Topical gel en Synonym Inactive Case insensitive SNOMED CT core
2660585012 Cutaneous gel (qualifier value) en Fully specified name Inactive Case insensitive SNOMED CT core
3541113018 Conventional release cutaneous gel en Synonym Active Case insensitive SNOMED CT core
3541114012 Conventional release cutaneous gel (dose form) en Fully specified name Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cutaneous gel Is a Gel false Inferred relationship Some
Cutaneous gel Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Cutaneous gel Is a Cutaneous dose form true Inferred relationship Some
Cutaneous gel Has dose form administration method Apply true Inferred relationship Some
Cutaneous gel Has dose form intended site Cutaneous true Inferred relationship Some
Cutaneous gel Has dose form release characteristic Conventional release true Inferred relationship Some
Cutaneous gel Has basic dose form Gel true Inferred relationship Some
Cutaneous gel Has dose form transformation No transformation true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Estradiol 600 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Testosterone 10 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Benzoyl peroxide 25 mg/g and clindamycin phosphate 12 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Terbinafine (as terbinafine hydrochloride) 10 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Chlorhexidine (as chlorhexidine gluconate) 40 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Silver nanoparticle 20 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Salicylic acid 60 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Salicylic acid 110 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Salicylic acid gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Benzoyl peroxide 100 microgram/mg cutaneous gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Metronidazole 7.5 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Metronidazole gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Metronidazole 8 mg/mL cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Metronidazole 10 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Adapalene 1 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Tetracaine 40 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Tetracaine hydrochloride 20 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Benzoyl peroxide 2.5% + clindamycin 1.2% topical gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Clindamycin 1.2%/tretinoin 0.025% topical gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Polynoxylin 100 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Adapalene 3 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Diclofenac sodium 30 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Ibuprofen 50 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Ketoprofen 25 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Piroxicam 5 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Ibuprofen 100 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Fluocinolone acetonide 250 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Tretinoin 100 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Tretinoin 250 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Erythromycin 20 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Erythromycin 40 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Erythromycin 20 mg/g and isotretinoin 500 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Nicotinamide 40 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Benzoyl peroxide 100 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Benzoyl peroxide 50 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Fusidic acid 20 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Heparinoid 3 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Lidocaine hydrochloride 5 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Lidocaine hydrochloride 10 mg/mL cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Lidocaine hydrochloride 20 mg/mL cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Calcium gluconate 25 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Isotretinoin 500 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Adapalene 1 microgram/mg cutaneous gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Becaplermin 100 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Desoximetasone 500 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Testosterone 1% gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Tretinoin 1 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Desoximetasone 0.5% gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Fluocinonide 500 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Betamethasone dipropionate 0.05% gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Clobetasol propionate 500 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Ibuprofen 50 mg/g and levomenthol 30 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Testosterone 50mg gel 5g sachet Has manufactured dose form False Cutaneous gel Inferred relationship Some
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Terbinafine hydrochloride 1% gel Has manufactured dose form False Cutaneous gel Inferred relationship Some
Tretinoin 400 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Lidocaine hydrochloride 20 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Azelaic acid 150 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Dapsone 50 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Desonide 500 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Ketoconazole 20 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Bexarotene 10 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Oxybutynin hydrochloride 100 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Tazarotene 1 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Benzoyl peroxide 25 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Dithranol 2.5 mg/g and salicylic acid 16 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Coal tar 50 mg/g and pine tar 50 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Tazarotene 500 microgram/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some
Diclofenac diethylammonium 11.6 mg/g cutaneous gel Has manufactured dose form True Cutaneous gel Inferred relationship Some

Reference Sets

Qualifier value foundation reference set

Medication form reference set

Back to Start